Literature DB >> 15615733

Disappointing results from Nova Vision's visual restoration therapy.

J C Horton.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15615733      PMCID： PMC1772467          DOI： 10.1136/bjo.2004.058214

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  8 in total

1.  Those that were blind can now see.

Authors:  C M Wessinger
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

2.  Restoration of vision II: residual functions and training-induced visual field enlargement in brain-damaged patients.

Authors:  E Kasten; D A Poggel; E Müller-Oehring; J Gothe; T Schulte; B A Sabel
Journal:  Restor Neurol Neurosci       Date:  1999       Impact factor: 2.406

3.  Stability of visual field enlargements following computer-based restitution training -- results of a follow-up.

Authors:  E Kasten; E Müller-Oehring; B A Sabel
Journal:  J Clin Exp Neuropsychol       Date:  2001-06       Impact factor: 2.475

4.  Visual field recovery from scotoma in patients with postgeniculate damage. A review of 55 cases.

Authors:  J Zihl; D von Cramon
Journal:  Brain       Date:  1985-06       Impact factor: 13.501

5.  Computer-based training for the treatment of partial blindness.

Authors:  E Kasten; S Wüst; W Behrens-Baumann; B A Sabel
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

6.  Scanning the visual world: a study of patients with homonymous hemianopia.

Authors:  A L Pambakian; D S Wooding; N Patel; A B Morland; C Kennard; S K Mannan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

7.  Saccadic eye movement strategies in patients with homonymous hemianopia.

Authors:  O Meienberg; W H Zangemeister; M Rosenberg; W F Hoyt; L Stark
Journal:  Ann Neurol       Date:  1981-06       Impact factor: 10.422

8.  Visual field rehabilitation in the cortically blind?

Authors:  R Balliet; K M Blood; P Bach-y-Rita
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-11       Impact factor: 10.154
  8 in total
  28 in total

1.  Vision restoration therapy.

Authors:  B A Sabel; S Kenkel; E Kasten
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

2.  Vision restoration therapy: confounded by eye movements.

Authors:  J C Horton
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

3.  Vision restoration therapy.

Authors:  L R Caplan; A Firlik; N J Newman; M Pless; J G Romano; N Schatz
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

4.  Vision restoration therapy and raising red flags too early.

Authors:  Bernhard A Sabel
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 5.  The blindsight saga.

Authors:  Alan Cowey
Journal:  Exp Brain Res       Date:  2009-07-01       Impact factor: 1.972

6.  Using Vision to Study Poststroke Recovery and Test Hypotheses About Neurorehabilitation.

Authors:  Ania Busza; Colleen L Schneider; Zoë R Williams; Bradford Z Mahon; Bogachan Sahin
Journal:  Neurorehabil Neural Repair       Date:  2019-02       Impact factor: 3.919

7.  Functional preservation and enhanced capacity for visual restoration in subacute occipital stroke.

Authors:  Elizabeth L Saionz; Duje Tadin; Michael D Melnick; Krystel R Huxlin
Journal:  Brain       Date:  2020-06-01       Impact factor: 13.501

Review 8.  Relearning to See in Cortical Blindness.

Authors:  Michael D Melnick; Duje Tadin; Krystel R Huxlin
Journal:  Neuroscientist       Date:  2015-12-10       Impact factor: 7.519

9.  Compensatory strategies following visual search training in patients with homonymous hemianopia: an eye movement study.

Authors:  Sabira K Mannan; Alidz L M Pambakian; Christopher Kennard
Journal:  J Neurol       Date:  2010-06-16       Impact factor: 4.849

10.  Homonymous Hemianopia: A Critical Analysis of Optical Devices, Compensatory Training, and NovaVision.

Authors:  Victoria S Pelak; Mark Dubin; Edward Whitney
Journal:  Curr Treat Options Neurol       Date:  2007-01       Impact factor: 3.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.